Episoder
-
Transforming health care systems is difficult, and yet that is the goal we are trying to achieve when we are leveraging the technologies of the future to address current health care challenges. And if you're a global multinational, the challenges can be even more complicated. Your day to day can be a mix of conflicting priorities, such as in dealing with the needs of today's business while also keeping an eye on the future, a future which includes health system transformations, personalized health, and health equity.
In this episode I speak with Ahmed Elhusseiny, the area head for Roche Pharma in Asia Pacific at their offices in Singapore to discuss how a global multinational can drive change.
During this podcast Ahmed and I discuss:
The importance of being mission-oriented to address systemic health challenges
How Roche’s approach to data-driven healthcare starts with understanding unmet customer needs
Examples of Roche’s effectiveness in Public-Private Partnerships
The new Economist Whitepaper supported by Roche highlighting APAC’s un-met needs in Breast Cancer
About Ahmend
Ahmed Elhusseiny has worked in the pharmaceutical industry for nearly 20 years, working across Europe, North America and Asia. He has a strong track record of developing and implementing comprehensive strategies for innovative health therapies. Prior to joining Roche in 2013, he was at Novartis for ten years, where he led various business units, including Ophthalmology and Primary Care.
Guest's Links and Resources
Connect with Ahmed: LinkedIn
Visit Roche
Episode PDF
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors.
Special thanks to:
Amalgam Rx | Bayer G4A | Lindus Health | LSI -
A key driver to create the future of health in both personalized health and health equity is innovation, an innovation that comes from technology. Startups who are creating disruptive products and services are typically fueled by venture capital investors. But how can startups and investors align with future end customers to create the health ecosystems of tomorrow?
In this episode, I speak with Scarlett Chen, Managing Partner at Verge HealthTech Fund. Throughout her career she's helped drive business growth as both an investor and through m & a.
During this podcast Scarlett and I discuss:
Defining HealthTech and why it is a necessary element for the future of health
About Verge as a fund and their focus on returns and impact
Trends and challenges in health tech investments from Verge’s State of HealthTech events
How to become a health tech / digital health success story
Thoughts on the next 18 months in HealthTech
About Scarlett Chenn
Ms Scarlett Chen is Managing Partner at Verge HealthTech Fund, a VC fund manager focused exclusively on impactful HealthTech startups at a global scale and at the early stage.
Previously as Managing Director at Prudential Corporation Asia, Ms Chen was responsible for Strategic Investments. Before Prudential, Ms. Chen worked at Anbang Capital as Global Head of Financial Institutions Group where she led a number of outbound investments in Europe and Asia.
Before joining the buy-side, Ms. Chen was an investment banker for over a decade, having worked at Merrill Lynch in the US and Barclays in Hong Kong, where she executed more than US$30 billion in capital markets and advisory transactions.
Guest's Links and Resources
Connect with Scarlett Chenn: LinkedIn
Visit Verge HealthTech Fund
Episode PDF
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors.
Special thanks to:
Amalgam Rx | Bayer G4A | Lindus Health | LSI -
Mangler du episoder?
-
Health systems are faced with many choices when it comes to population health. Increasing costs for sick care, decisions on which innovations they can approve and afford, and evolving medical practices in both prevention and treatment which can challenge existing regulatory norms.
In this episode, I speak with Clive Tan, a Founding Member of Precision Public Health Asia Society to discuss how their work is serving to harmonise the decisions the ASEAN region is making to improve population health. The Society recently held their biennial event in Singapore, including esteemed speakers including Singapore’s Minister of Health Ye Kun Ong.
During this podcast Clive and I discuss:
The definition of "precision public health" and how it has evolved over the past decade
Singapore’s HealthierSG programme
How economic growth in ASEAN countries is impacting public health priorities
Main takeaways from the leadership forum in terms of country development and collaboration opportunities
The regulatory opportunities discussed at the leadership forum
About Clive Tan
Clive Tan is a medical doctor and Public Health specialist with close to two decades of clinical and leadership experience in the healthcare sector. As Assistant Chief of Group Integrated Care (Population Health) in the National Healthcare Group, he is responsible for strategic planning for integrated care and population health efforts for the 1.5 million residents in the Central-North region of Singapore. His work in care integration incorporates value-based care, behavioral change incentives, payment models, healthcare quality and digitalization – with a strong emphasis on place-based care and relationship-based care. He holds a MBBS from Singapore and a Masters in Public Health (MPH) from Johns Hopkins University, along with certificates in Gerontology, Humanitarian Assistance and Health Informatics (AMIA). He is also an Atlantic Fellow in the Equity Initiative Programme, which works in South-East Asia to reduce health inequities. Together with the National University of Singapore’s School of Public Health and the Precision Public Health Asia Society, he recently published the White Paper on Responsible Data Sharing in Health and Healthcare in May 2022, which outlines useful and practical steps that stakeholders can take to build a more progressive state of data sharing in the health sector. He is a Founding Member of the Precision Public Health Asia Society, and was the organizing chairperson for the Precision Public Health Asia Conference, held in Singapore in July 2023. He is an adjunct Assistant Professor at the National University of Singapore’s School of Public Health where he teaches healthcare management, digital health and data sharing in health.
Guest's Links and Resources
Connect with Clive Tan: LinkedIn
Visit Precision Public Health Asia Society
Definition of ASEAN
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors.
Special thanks to:
Amalgam Rx | Bayer G4A | Lindus Health | LSI -
Today, we are more fascinated than ever by how Artificial Intelligence can affect the future of any industry, including healthcare. But AI alone can’t solve healthcare. To make an impact, solutions built with AI have to fit into the right ecosystem to enable better consumer journeys and health outcomes.
In this episode, I speak with Prashant Warier, the co-founder and CEO of Qure. Over the past 6 years, he’s learned how to convert the promise of how Artificial Intelligence can be used in Healthcare into three clear use-cases that solve the needs of millions of people across 80 countries.
During this podcast, we discuss:
• The value of mentors and advisors to help identify disruptive opportunities that drive exponential change in healthcare
• How a background in Data Science changed the way to develop effective AI products
• The three clear use-cases for AI and Radiology that led to reaching millions of people across 80 countries by focusing on autonomous X-Ray interpretation
• How a team of 250 people can scale by building effective partnerships with organisations like Astra Zeneca and the NHS
About Prashant Warier
Prashant Warier is Founder and CEO of Qure.ai, a leading Artificial Intelligence company in Radiology. He is an expert in the field of artificial intelligence and machine learning and has architected and commercialized several AI solutions during his career. His work has been published in journals such as The Lancet and Nature. He is passionate about using AI and machine learning to make healthcare affordable and accessible. Prashant is an evangelist for the adoption of AI in radiology and has given multiple TedX talks, including one at the largest TedX event in the world in Mumbai. In the past, Prashant was Chief Data Scientist at Fractal.ai and also founded AI - powered advertising technology startup Imagna which was acquired by Fractal.ai in 2015.
Guest's Links and Resources
Connect with Prashant Warier: LinkedIn
Qure.ai
Qure Impact Page
NHS AI Toolkit
Global Health AI Tool Kit (for SEA and India)
Episode PDF
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Amalgam Rx | Bayer G4A | Lindus Health | LSI -
Engaging with active and well-informed individuals is the essential element of any successful health ecosystem. Without them, healthcare and digital health companies are building solutions that can’t improve health outcomes. Patient advocacy groups are one way that individuals can become empowered. But across the world, the impact of such groups is dependent on external factors to help them achieve scale. In this episode, I speak with Ruth Kuguru, the Regional Head for Communications and Patient Engagement for Novartis who has developed a platform to change this dynamic for patient advocacy groups. During this podcast, we discuss:
How Novartis created a platform to bring together different stakeholders and putting patients at the forefront of improving Habitats – another word for Ecosystems
Describing the components of the Alliance & Partnerships for Patient Innovation & Solutions (APPIS) including a case study in the Philippines
Why patient advocacy groups are the “real deal” for creating engaged individuals
Scaling the impact of patient advocacy into a corporate capability that goes beyond the traditional model for pharma manufacturers
About Ruth Kuguru
Ruth Kuguru is the Executive Director, Communications & Patient Engagement for Novartis Asia Pacific, Middle East, and Africa. In her role, she leads her team to foster open, inclusive, and strong partnerships with patient communities, media, and healthcare leaders in Asia Pacific, Middle East and African countries. She is passionate about the impact strong collaboration can have in accelerating access and developing innovative solutions for patients.
Guest's Links and Resources
Connect with Ruth Kuguru: LinkedIn
Novartis: Website
APPIS Summit
APPIS Innovator Programme
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Amalgam Rx | Akili | Bayer G4A | Lindus Health -
Join host Tony Estrella each month as he explores with his guests what it takes to build successful ecosystems across Asia-Pacific.
You’ll hear thought-provoking interviews with industry leaders, entrepreneurs, and investors who bring real-life examples of building effective partnerships that solve some of the most important healthcare challenges across this vibrant region.
Whether you’re already in healthcare, a tech enthusiast, or simply curious about what is happening in Asia-Pacific, tune in to the APAC Edition of Digital Health Today.
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Amalgam Rx | Akili | Bayer G4A | Lindus Health -
Globally, the insurance industry is rapidly changing with the increasing use of technology throughout the value chain. And because individuals in Asia Pacific tend to buy and use health insurance from life insurers, the need for data, customer engagement, and digital transformation is particularly essential.
In this episode, I speak with Paul Hughes, the Head of Asia Pacific for UnderwriteMe. Paul and I first worked together at MetLife Asia many years ago, and he has worked across Asia Pacific for many other private insurers. In his current role, he is at the epicenter of the change spurred by technology and data, including digital health.
In this episode, we discuss:
• The structure of the typical insurance, from sales to operations
• How technology and data are changing the way insurers need to operate
• The role of digital tools including health and insurtech
• The future of underwriting
Paul Hughes
Paul leads the Asia Pacific team at UnderwriteMe, a leading provider of underwriting automation solutions that helps insurers transform their new business process. He is responsible for creating and leading the growth strategy for the business in Asia Pacific and ensuring client success. With over 25 years of experience in the life and health insurance industry in Asia Pacific, he had held senior roles in Underwriting, Claims, Operations, Product and Marketing with leading insurers and reinsurers such as Swiss Re, Aviva, AIA, and MetLife.
Guest's Links and Resources
Connect with Paul Hughes: LinkedIn
UnderwriteMe: Website | LinkedIn | Twitter |
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Takeda
Roche -
The role of academia is an essential one for digital health. In addition to providing the platform to conduct clinical research and showcase where technology can create impact, the right environment also becomes the training ground for future leaders and change makers.
In this episode, I speak with Dean Ho, who is one of the unique individuals who effectively bridges the different worlds of academia and business building. Dean is the Provost’s Chair Professor, Director of The N.1 Institute for Health (N.1), Director of the Institute for Digital Medicine (WisDM), and Head of the Department of Biomedical Engineering at the National University of Singapore. He's also an experienced business builder and entrepreneur.
In our conversation we cover:
• The evolving role of academia in becoming a hands-on partner for Health Innovation
• The impact of Digital Health including AI on regulatory
• How National University of Singapore is taking a role in designing the next generation of clinical innovation
• The need for Digital Therapeutics in APAC
Professor Dean Ho
Using his CURATE.AI platform, Prof.Dean Ho has led multiple pioneering clinical studies that have validated the promise of N-of-1 medicine, where only a patient’s own data is used to personalise their treatment for the entire duration of care. Multiple CURATE.AI-based clinical studies are ongoing or cleared for start in the areas of solid cancer and blood cancer therapy, digital therapeutics/personalised learning, and post-organ transplant immunosuppression, among others.
Prof. Ho is an elected member of the US National Academy of Inventors (NAI). He is also a Fellow of the American Institute of Medical and Biological Engineering (AIMBE), the Royal Society of Chemistry, and Society for Laboratory Automation and Screening, as well as a Fulbright Scholar. Prof Ho is also currently a Subgroup Lead of the World Health Organization-ITU AI for Health Working Group for Regulatory Considerations. He has also served as the President of the Board of Directors of the Society for Laboratory Automation and Screening (SLAS), a 26,000+ member global drug development organization comprised of senior executives from the pharmaceutical and medical device sectors, as well as academic thought leaders.
Prof. Ho is a recipient of the Tech Heroes from Crisis: Pathfinder Award from the Singapore Computer Society, NSF CAREER Award, Wallace H. Coulter Foundation Translational Research Award, and V Foundation for Cancer Research Scholar Award, among others. Prof. Ho was also named to the Asia Tatler Gen.T List, which honours young leaders who are shaping the future of the region. Prof. Ho has appeared on the National Geographic Channel Program “Known Universe” to discuss his discoveries in drug delivery and imaging. His discoveries have been featured on CNN, The Economist, Forbes, Washington Post, NPR and other international news outlets. He has advised major publicly listed companies as well as venture capital and private equity funds in the areas of digital medicine and pharmaceutical development, among other sectors.
Guest's Links and Resources
Connect with Dean Ho: LinkedIn | Twitter
The N.1 Institute for Health (N.1): Website | Twitter | LinkedIn
WisDM: Twitter
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Takeda
Roche -
For some Digital Health companies, especially those in very developed healthcare systems, success can be contingent on identifying a single core problem and then keeping a tight focus on this challenge when iteratively building your great solution. But not every entrepreneur or corporate innovator has the luxury to take this path, especially when there are overlapping areas of need for your customers.
In this episode, we return to Indonesia to examine both the challenge and the successful approach taken by Tiffany Robyn Soetikno, the Founder and COO of PT Global Urban Esensial. Robyn is a skilled entrepreneur who grew up in the Indonesian Healthcare industry. The results (so far) from her efforts have led to a startup delivering impact for 2.5 million individuals, 70,000 doctors, and 1,700 pharmacists.
In our discussion, we cover:
• A summary of the Indonesia healthcare landscape
• Building a complex product roadmap and making it work
• Her process for deriving consumer insights
• Building scale across each of the different customers while managing growth
Robyn Soetikno
Robyn founded PT Global Urban Esensial (PT GUE, LLC), a leading digital health startup in Indonesia with a vision to reduce the relationship gaps between doctors and patients. Driven to create a health ecosystem that connects different stakeholders, GUE, LLC has developed three pillars: patient management, doctor management and medication supply.
Robyn is passionate about enabling stakeholders within the healthcare industry, using technology to address gaps in the healthcare sector. As a startup founder, she has experience in making the jump from zero to one, scaling up, and transforming the team accordingly. She has also assisted several incumbents to grab opportunities in digital.
In 2019, Robyn was named 30 Under 30 - Asia - 2019 under Healthcare and Science category. She was the only Indonesian entrepreneur honored by Forbes.
Robyn earned her Masters of Science degree in International Health Management from Imperial College, London and her Bachelor of Arts in Psychology, Public Health and Theatre from Sarah Lawrence College, New York.
Guest's Links and Resources
Connect with Robyn Soetikno: LinkedIn
PT Global Urban Esensial: LinkedIn
Guesehat: Website | Facebook | Twitter | Instagram | YouTube
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Takeda
Roche -
Across Asia Pacific, one persistent challenge is the digital readiness of a health system. Some are more ready for Health Tech than others. The ones that are most prepared have significant adoption of technology, data standards, and processes that embed tech-based solutions into healthcare.
In this episode, I’m joined by Shigeto Miyamoto, Head of Digital Marketing for BMS in Japan, and a life-long evangelist for driving technology innovation. In our conversation, we take a deep dive into the current digital readiness in Japan. And while the discussion is specific to one country, the insights from our discussion can be applicable to other health systems.
Topics we discuss include:
• Cultural reasons why paper-based processes are still prevalent
• Gap between the desire to innovate and barriers including regulatory
• The impact of COVID on the use of smartphones, telemedicine, and EMRs
• Cultural views on privacy and data
• The hopeful future for Digital Health in Japan including AI and IoT / Smart Devices
Shigeto Miyamoto
Based in Tokyo, Shigeto Miyamoto is an experienced digital marketer and thought leader for how technology is driving disruptive innovation in Japan. Shigeto is currently the Head of Digital Marketing at BMS Japan, where he is the lead for engagement strategy, contents capabilities, and marketing technology. He has previously worked in insurance at MetLife Japan and held other technology-centric roles at both global enterprises and startups.
His career choices are driven by a mission to solve the medical and digital disparities for patients. Shigeto is best known for inspiring marketers to tackle challenging problems through agile thinking and iterative product creation.
Guest's Links and Resources
Connect with Shigeto Miyamoto: LinkedIn
Bristol-Myers Squibb (BMS): Website | LinkedIn | Twitter | Facebook | Instagram
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Takeda
Roche -
In any health system, a shift to value based healthcare is a desirable outcome. Especially if it can be combined with patient-centric clinical journeys.
In this episode, Sylvana Sinha, the founder and CEO of Praava Health and I discuss the barriers and challenges to achieving this vision.
With her background in health policy, international law, and as an entrepreneur, we have an insightful and fact-filled discussion covering topics including:
• The cultural and socio-economic backdrop of Bangladesh, the 8th most populous country in the world
• The current dynamics of access and affordability facing Bangladeshis today
• The barriers and inefficiencies in creating a value-based healthcare system, including lack of labs, pharmacies, and overall accountability
• Lessons learned from Praava Health in addressing these challenges
• How COVID accelerated the need for more technology and new value based models
Sylvana Sinha Founder, Chair, & CEO
Ms. Sinha is the Founder and CEO of Praava Health in Bangladesh. Praava Health is building Bangladesh’s fastest growing consumer healthcare brand and raising the bar for healthcare with a brick-and-click healthcare platform that combines digital tools with meaningful doctor-Patient relationships, quality diagnostics, and pharmacy services. In May 2020, Fast Company recognized Praava Health in its 2020 World Changing Ideas Awards, and the World Economic Forum named Praava as a Technology Pioneer in 2021.
She is now poised to scale the Praava model nationally, and to deepen Praava’s brick-and-click service delivery model. Ms. Sinha built this company from scratch, largely based on inspiration derived from conversations with public health professionals, entrepreneurs, and investors in India and Asia and beyond, learning from what had worked in other markets and what made sense for Bangladesh at this moment of its economic development.
Ms. Sinha is as Life Member of the Council on Foreign Relations. She also serves as a member of the World Economic Forum’s UHC2030 Private Sector Constituency and served on the Task Force on Global Advantage at the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai. She is a graduate of Columbia Law School, where she earned a certificate from the Parker School of Comparative and International Law. She also earned a master's degree in Public Administration / International Development from Harvard's Kennedy School and her Bachelor of Arts (with honors) in Economics and Philosophy from Wellesley College and also was a Visiting Scholar at the University of Oxford studying politics, philosophy, and economics.
Guest's Links and Resources
Connect with Sylvana Sinha: LinkedIn
Praava Health: Website | LinkedIn | Twitter | Facebook | Instagram
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Takeda
Roche -
In this episode, we’re taking a deep dive into Indonesia. For some, the mention of this country might evoke extreme feelings. On one hand, there is the frustration of sitting in four-hour-long traffic jams in Jakarta. On the other hand, there are smiles all around when picturing a perfect holiday in Bali.
But for healthcare professionals, the identity of Indonesia is dominated by the unique geography of the country – a population of 275 million people living across 6,000 islands.
To help us better understand the healthcare challenges in Indonesia, which extends across more than 17,000 islands, I’m joined by one of its most visible entrepreneurs: Jonathan Sudharta, CEO of Halodoc. Founded in 2016, the company raised an $80 million Series C in 2021.
In this episode, you’ll hear about:
• Access and affordability challenges stemming from Indonesia’s economic development, demographics, and archipelago geography
• The impact of Universal Healthcare, introduced in 2014
• The opportunity and early impact of digital health – including Halodoc – on health outcomes
Jonathan Sudharta, Co-founder and CEO
Jonathan Sudharta has over 15 years of professional experience in the healthcare industry, mostly in Indonesia and also abroad. Before establishing Halodoc, Jonathan held several key positions in Mensa Group, one of the leading pharmaceutical companies in Indonesia.
After graduating with a Bachelor of Commerce majoring in e-Commerce from Curtin University in Perth Australia, he began his career in sales management and has grown through the ranks in the commercial side of the organization. He started as a sales representative, after which he became the Commercial Director in Mensa Group where he gained a deep understanding of the sales cycle of the business, and finally he moved up to the key position of Business Development Director to lead the commercial initiatives of the group.
Born in a healthcare group family, Jonathan grew up with a lot of awareness about serving people to maintain their wellness and helping Indonesian people achieve a better living through better health. That is the main reason why he decided to establish Halodoc, whose main mission is to simplify access to healthcare through the use of technology.
Indonesia’s healthcare has many critical challenges, some of these are the inequality of health services across the archipelago, time-to-service for health in the urban areas, and so on.
The aforementioned challenges require a breakthrough to solve from the fundamental level, thus technology is the key to attack the problems from the roots.
Guest's Links and Resources
Connect with Jonathan Sudharta: LinkedIn
Halodoc: Website | LinkedIn | Twitter
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Takeda
Roche -
In this episode, we speak about the global challenge of mental health. With COVID, the WHO is predicting that “the mental health impacts of the pandemic will be long term and far-reaching.” Everyone can be affected, including caregivers and clinicians.
Nawal Roy is CEO of Holmusk, a leading startup helping address the global challenge of mental health through their real world evidence platform.
In our conversation, we cover the following topics:
• Understanding the main categories for mental health
• Similarities of mental health challenges in APAC and around the world
• Areas of opportunities for digital health
• The current status and future needs of evidence to unlock clinical innovations
Nawal Roy (Founder & CEO, Holmusk)
Nawal Roy is Founder and CEO of Holmusk, bringing more than fifteen years of finance and strategy consulting experience to the helm of the company. After seeing first-hand the transformation of the finance sector driven by data and technology, Nawal decided to focus on helping transform healthcare in the same way. There is an urgent need for more behavioral health evidence and this need is what spurred Nawal to start Holmusk. Nawal carves out the strategic direction of Holmusk, leading from the front with round-the-clock hustle and infectious energy.
Prior to this, Nawal was Co-Founder and CEO of HelloPay (Rocket Internet venture), and a Junior Partner at McKinsey & Company. He has served as a World Economic Value-Based Healthcare Steering Committee and co-founded Galen Growth Asia - The Asia Health Tech Connector. Having enjoyed a global career spanning from New York to Tokyo, his close involvement with markets across North America, Europe, Southeast Asia, India, and China yields uniquely diverse experience in building next generation global companies.
Guest's Links and Resources
Connect with Nawal Roy: LinkedIn
Holmusk: Website | LinkedIn | Twitter
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Takeda
Roche -
In this episode, we start our journey for Season 2 where we explore the challenges facing APAC that can lead to innovative solutions powered by Digital Health.
Jeremy Lim is a renowned health policy expert and CEO of AMILI, the first gut microbiome lab in Singapore and Southeast Asia. Through the lens of population health and public policy, Jeremy and I discuss the need for personalised nutrition and why it can improve health outcomes.
Our conversation covers:
• The need for an Asia-based pool of data on nutrition based on the unique cultures and food choices found across the region
• Why personalised nutrition is another reason for public health to innovate beyond a “one-size fits all” approach
• The challenge of successfully using nudging behaviours to improve health outcomes
• When is the optimal time to understand your microbiome?
Assoc Prof Jeremy Lim is Co-founder and CEO of AMILI, the region’s first precision gut microbiome company which is building up the world’s largest multi-ethnic Asia database of microbiome sequences and associated data. He brings diverse and unique perspectives into this role as a startup founder, having spent substantial time in public and private healthcare across Asia as well as in policy advisory with Singapore's Ministry of Health, the World Bank and the World Health Organization.
He is also director for global health in the NUS Saw Swee Hock School of Public Health. Outside academia, Jeremy serves on the boards of various for-profit and not-for-profit organizations in different aspects of healthcare including migrant worker health, end of life care and digital health interventions. He trained in surgery and public health, attaining post-graduate qualifications in both from the UK and US.
Guest's Links and Resources
Connect with Jeremy Lim: LinkedIn
AMILI: Website | LinkedIn
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Takeda
Roche -
In this episode, I speak with Dan Kendall, founder of Digital Health Today, to reflect on highlights from this season and preview what we will cover in Season 2 of Digital Health Today, Asia Pacific Edition.
Click on the show links or scroll through the playlist in your favorite podcast player to hear more from these and our other Season 1 guests.
Be sure to hit the subscribe button to be notified when Season 2 starts in a few weeks!
“What are the opportunities out there for people to live in good health, to be independent, and to be dignified? This goes across technologies, housing models, and service innovations.”
— Janice Chia, Ageing Asia
”In a healthcare ecosystem, party interests-- of patients, health providers, funders, government and private insurance-- are not aligned. This results in a lack of help for patients to find the treatment they need, and funders cannot intervene early enough to help keep costs under control.”
— Xing Sun, AXA Next Business Innovation Centre Asia
”On average across Southeast Asia, you know, patients will actually visit a pharmacy almost 12 times a year, but when they visit a physician, it’s almost 1.2 times a year, right. So when you look at this, this becomes an incredible touch point in terms of patient population.”
— Farouk Meralli, CEO of mClinica
"When we started out in March, telemedicine was completely illegal in India; there was no way you could tele-consult and give a prescription. So the first telemedicine guidelines were brought out by the government on March 25, 2020. Before that, everything was completely illegal in fact, but the government responded very quickly, considering the pandemic was there. And now everything is well established, and there are clear cut guidelines and rules…within a matter of months, we were doing about 35,000 consults across digital health every month.”
— Shuchin Bajaj, Founder and Director for Ujala Cygnus
"We should not use our own mentality or our mindset to replace users’ mindset. Sometimes it’s pretty frustrating, because we know we are smarter than them, but you cannot replace them. You have to think in their own way. You have to think of yourself as the user, not yourself. You have to pretend to be a pregnant mother, who just has a high school education, and figure out what her mindset would be.”
— Stanley Li, CEO and Founder of DXY
>> Click here to read the transcript
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Cedars-Sinai Accelerator
Takeda
Roche -
For more than 20 years, Stanley Li has built an impressive set of solutions for the China market. With more than 2 million doctors as customers and millions of consumers engaging with their offerings, DXY is one of the largest health services companies in the world.
Stanley graciously sat with me and shared many lessons over his journey to solve challenges ranging from:
Physician education
Online and offline community building
Adapting to changing needs as China grew to become a digital-first economy
Stretching the mission of DXY from sick care to prevention
How he builds trust with his customers
Future partnership priorities
Stanley (Tiantian) Li has a Master degree in Tumor Immunology and is a visiting professor of the Second Military Medical University in China. He co-founded DXY (the largest physician social network in China) in 2000. To date, DXY has raised over $680 million in funding, and it's most recent funding round, led by private equity firm Trustbridge Partners has raised $500 million. Read more about it here.
>> Click here to read the transcript
Guest's Links and Resources
Connect with Stanley Li: LinkedIn | Twitter | WeChat @TiantianDXY
Visit DXY: Website | LinkedIn |
DXY 500 million funding
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Cedars-Sinai Accelerator
Takeda
Roche -
Dr Shuchin Bajaj is the Founder Director of Ujala Cygnus Hospitals. Ujala Cygnus currently operates twelve hospitals that provide healthcare to district towns of the states of India where emergency and primary care are difficult to find.
As a doctor and entrepreneur, Dr Bajaj is truly making a difference by infusing innovation throughout every aspect of patient care.
During our conversation we cover:
Access and affordability challenges across India
The challenge of building a new provider system from the ground up
The impact of effective community outreach
How COVID-19 changed the regulatory limitations on telemedicine and accelerated the use of other digital health solutions beyond telehealth
Dr Bajaj is a highly qualified and accomplished medical scholar. He has completed his M.B.B.S., M.D. (Internal Medicine), as well as the Certified Professional course on Diabetes Management and Total Control (American Academy of CME), the A.P.S.M. (I.I.M., Calcutta), and the Advanced Program in Cardiac Emergencies (Boston University). HE is the IHT Fellow (INSEAD, France), Aspire Fellow, and recipient of the Cohort Stanford Seed.
Also, he received the 2015 Chevening Gurukul Fellowship for Leadership and Excellence Award from King’s College, London where he spent considerable time studying the various facets of Leadership, its various challenges, and its learnings for India.
He is on the board of several national prominent NGOs as Advisor-Health Programmes and is the recipient of numerous awards and accolades including the “World Wide Achievers Health Care Excellence Award 2014” for Healthcare Excellence in Internal Medicine in Delhi and NCR, ”Best Consultant in Internal Medicine in Delhi 2012” by the Time Research Media Foundation, “National Award for Excellence in Healthcare 2015” for fastest growing healthcare chain in North India along with “2015 Leaders Award”.
Dr Bajaj and the Cygnus Team were recently featured by the Economic Times in a feature on Entrepreneurs Leading Disruptive Change. Dr Bajaj is also the winner of the Healthcare Leader of the Year, 2017 Awards.
Dr Bajaj is an avid Healthcare Investor and is associated with multiple Health Tech Companies as an investor, Board Member, and mentor. He is on the TBIU Board of IIT, Delhi, and is also a member of the Advisory Council to the Minister of State for Health, Shri Ashwini Choubey.
>> Click here to read the transcript
Guest's Links and Resources
Connect with Dr Shuchin Bajaj: LinkedIn
Visit Ujala Cygnus Hospitals: Website | LinkedIn | Instagram | Facebook
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Cedars-Sinai Accelerator
Takeda
Roche -
Ageing and the business of helping individuals as they get older is an expansive problem. It cuts across industries beyond healthcare.
Singaporean entrepreneur Janice Chia is a recognized expert and thought leader in this field, accumulating her vast experience from visiting over 400 residential and aged care homes in over 15 countries as well as founding 2 organizations: Ageing Asia and Aspire55.
Janice founded Ageing Asia with the mission to drive innovation in the way future generations age, by engaging the business community to create better products and services that will enable healthy ageing, independent ageing and dignified ageing. Since 2009, she has been actively involved in consulting organizations seeking global best practices in housing, health and care models that can be translated for the Asian market.
Join me as we discuss:
What drove Janice to create a new organization to better define the challenges of ageing?
What is the mindset of people who are in the second half of their lives?
Why is this challenge broader than a healthcare challenge?
Why are the needs of digital health solutions broader than telehealth?
Janice frequently refers to data from the 4th Annual Asia Pacific Silver Economy Business Opportunities Report. The link to this can also be found below.
>> Click here to read the transcript
Guest's Links and Resources:
Connect with Janice Chia: LinkedIn
Visit Ageing Asia: Website | Twitter | LinkedIn | Instagram | Facebook
4th Annual Asia Pacific Silver Economy Business Opportunities Report
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Cedars-Sinai Accelerator
Takeda
Roche -
Across Asia Pacific, the prevalence of chronic disease is increasing rapidly. Both public and private sector insurance providers are faced with challenging choices on how to balance health outcome improvements with increasing costs.
In this episode, Xing Sun and I discuss:
The basics of public health and private insurance, including critical illness insurance
How individuals buy insurance
The role digital health takes for insurers
Case studies from AXA including payer to partner strategies
Xing Sun is the Head of AXA Next Business Innovation Centre Asia, a hub dedicated to connect AXA to the Asia tech ecosystems and scale innovative business models through partnerships with InsurTech, HealthTech and FinTech players at a global scale.
>> Click here to read the transcript
Guest's Links and Resources:
Connect with Xing Sun: LinkedIn
Visit AXA: Website | Twitter | LinkedIn | Instagram | Youtube
AXA Next Business Innovation Centre
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Cedars-Sinai Accelerator
Takeda
Roche -
Value-based healthcare aligns the incentives of patients, providers, and payers to deliver better health. In Asia Pacific, provider groups have traditionally operated on a cash or fee-for-service model. This structure puts pressure on public health systems.
In this episode, we’ll learn:
Why it is challenging to achieve value-based healthcare
The opportunity for a digital gateway to engage individuals
What ecosystem is required to achieve value-based healthcare including public and private partnerships
How clinical expertise + technology leadership are required to stitch this ecosystem together
Dr. Patel moved to Singapore from the US in 2008 to found and lead the healthcare team at the Chandler Corporation, a multi-billion dollar investment fund. Prior to practicing law at Cravath, Swaine & Moore, LLP in New York, Dr. Patel received an MD and a JD from Columbia University and served as a Clinical Fellow at the Harvard Medical School.
>> Click here to read the transcript
Guest's Links and Resources:
Connect with Snehal Patel: LinkedIn
Visit MyDoc: Website | LinkedIn | Facebook | YouTube
Host's Links and Resources:
Connect with Tony Estrella: Twitter | LinkedIn | Personal Website
Connect with Taliossa
Read Tony’s Book: Comatose
FutureProofing Healthcare | FutureProofing Healthcare APAC index
Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Special thanks to:
Bayer G4A
Cedars-Sinai Accelerator
Takeda
Roche - Se mer
